Our Vision, Mission and Core Values

Launched in September 2012, TransCelerate Biopharma Inc. aims to simplify and accelerating the delivery of innovative medicines to patients. With so much progress and so much future opportunity, we have continued to refine our focus. The new statements below reflect our organization’s continued commitment:

Our Vision

To improve the health of people around the world by accelerating and simplifying the research and development of innovative new therapies.

Our Mission

To collaborate across the global biopharmaceutical R&D community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high quality delivery of new medicines.

Our Core Values

Transparency & Openness
Trust & Integrity

Learn More

For Sites & Training Providers

Resources for Sites and Training Providers, including common Sponsor forms and criteria for GCP  training that are mutually recognized by TransCelerate Member Companies, are available by clicking the button below.

Learn More

Our Events

TransCelerate executives and members present at many industry conferences and meetings all across the globe.  Click on the button below to see a comprehensive list of these events.

Learn More

Latest News

TransCelerate Publishes RBM Recommendations for Central Monitoring and Technology Considerations

TransCelerate has published risk-based monitoring (RBM) recommendations for central monitoring and technology considerations.  Two manuscripts published in the Drug Information Association’s Therapeutic Innovation & Regulatory Science journal, provide in-depth insights into these concepts pertinent to RBM methodology.  Access to the two new manuscripts is available here and here.  Read more here.

CDISC Announces Launch of CDISC eSHARE

CDISC and TransCelerate BioPharma Inc. announce launch of eSHARE. Read more here.

TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports

TransCelerate has developed a recommended approach for protecting personal data in Clinical Study Reports (CSRs) that are shared with researchers, patients and others. The document describes an approach to apply when redacting or removing personal information from CSRs and other related clinical trial documents. Read more here.